Abstract
Glioblastoma multiforme (GBM) is the most common adult primary brain tumor and is comprised of a heterogeneous population of cells. It is unclear which cells within the tumor mass are responsible for tumor initiation and maintenance. In this study, we report that brain tumor stem cells can be identified from adult GBMs. These tumor stem cells form neurospheres, possess the capacity for self-renewal, express genes associated with neural stem cells (NSCs), generate daughter cells of different phenotypes from one mother cell, and differentiate into the phenotypically diverse populations of cells similar to those present in the initial GBM. Having a distinguishing feature from normal NSCs, these tumor stem cells can reform spheres even after the induction of differentiation. Furthermore, only these tumor stem cells were able to form tumors and generate both neurons and glial cells after in vivo implantation into nude mice. The identification of tumor stem cells within adult GBM may represent a major step forward in understanding the origin and maintenance of GBM and lead to the identification and testing of new therapeutic targets.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF . (2003). Proc. Natl. Acad. Sci. USA, 100, 3983–3988.
Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ, Tang Y, DeFrances J, Stover E, Weissleder R, Rowitch DH, Louis DN and DePinho RA . (2002). Cancer Cell, 1, 269–277.
Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S and Gallo V . (2003). J. Cell Biol., 161, 169–186.
Bonnet D and Dick JE . (1997). Nat. Med., 3, 730–737.
Dick JE . (2003). Proc. Natl. Acad. Sci. USA, 100, 3547–3549.
Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, Black KL and Yu JS . (2004). Neoplasia, 6, 287–293.
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A . (2004). Cancer Res., 64, 7011–7021.
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI . (2003). Proc. Natl. Acad. Sci. USA, 100, 15178–15183.
Holland EC . (2001). Curr. Opin. Neurol., 14, 683–688.
Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN . (2000). Nat. Genet., 25, 55–57.
Holland EC, Hively WP, DePinho RA and Varmus HE . (1998). Genes Dev., 12, 3675–3685.
Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD and Steindler DA . (2002). Glia, 39, 193–206.
Kabos P, Ehtesham M, Kabosova A, Black KL and Yu JS . (2002). Exp. Neurol., 178, 288–293.
Katsetos CD, Del VL, Geddes JF, Aldape K, Boyd JC, Legido A, Khalili K, Perentes E and Mork SJ . (2002). J. Neuropathol. Exp. Neurol., 61, 307–320.
Kondo T and Raff M . (2000). Science, 289, 1754–1757.
Kondo T, Setoguchi T and Taga T . (2004). Proc. Natl. Acad. Sci. USA, 101, 781–786.
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE . (1994). Nature, 367, 645–648.
Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA and Dick JE . (1996). Nat. Med., 2, 1329–1337.
Lendahl U, Zimmerman LB and McKay RD . (1990). Cell, 60, 585–595.
Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK and Buck DW . (1997). Blood, 90, 5013–5021.
Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann 2nd G, Jiang L, Kang J, Nedergaard M and Goldman SA . (2003). Nat. Med., 9, 439–447.
Reynolds BA and Weiss S . (1992). Science, 255, 1707–1710.
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB . (2003). Cancer Res., 63, 5821–5828.
Surawicz TS, Davis F, Freels S, Laws Jr ER and Menck HR . (1998). J. Neurooncol., 40, 151–160.
Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL . (2000). Proc. Natl. Acad. Sci. USA, 97, 14720–14725.
Zhu Y and Parada LF . (2002). Nat. Rev. Cancer, 2, 616–626.
Acknowledgements
This work was supported in part by NIH grants 1K23 NS02232 and 1R01 NS048959 to JS Yu. We thank Dr Phillip H Koeffler for the critical review of the manuscript and helpful comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuan, X., Curtin, J., Xiong, Y. et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392–9400 (2004). https://doi.org/10.1038/sj.onc.1208311
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208311
Keywords
This article is cited by
-
Activated T cell therapy targeting glioblastoma cancer stem cells
Scientific Reports (2023)
-
Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment
Cellular and Molecular Neurobiology (2023)
-
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449
Journal of Neuro-Oncology (2023)
-
The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target
Medical Oncology (2022)
-
Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme
Oncogene (2020)